Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPSAB1 | Q15661 | 7/20 | 0.45 |
| ▸ | TPSD1 | Q9BZJ3 | 7/20 | 0.45 |
| ▸ | TPSG1 | Q9NRR2 | 7/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.33 |
| ▸ | BRD4 | O60885 | 3/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17402089 | 1.00 | TPSAB1 (0.45) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL19692282 | 1.00 | TPSAB1 (0.45) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL19692284 | 1.00 | TPSAB1 (0.45) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| Hydrochloric Acid SCHEMBL30689874 | 0.99 | TPSAB1 (0.44) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL21261851 | 0.91 | EPHX1 (0.46) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL14217877 | 0.88 | EPHX1 (0.56) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL24091968 | 0.87 | EPHX1 (0.45) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL22224323 | 0.86 | EPHX1 (0.59) | TPSAB1TPSD1TPSG1EPHX1GAA | |
| SCHEMBL24263885 | 0.85 | GAA (0.58) | EPHX1GAABCHE | |
| SCHEMBL20904214 | 0.84 | EPHX1 (0.49) | TPSAB1TPSD1TPSG1EPHX1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894091-B2 | Linker units and molecular constructs comprising the same | Immunwork Inc. (TW) | 2021-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894091-B2 | Linker units and molecular constructs comprising the same | CD2BP2, BCR, UACA | TPSAB1 3958/4885TPSD1 4493/4885TPSG1 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.